BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 35280503)

  • 1. Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU).
    Jang JH; Yang EM; Lee Y; Ye YM; Moon J; Ryu MS; Park HS
    World Allergy Organ J; 2022 Feb; 15(2):100629. PubMed ID: 35280503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria.
    Jang JH; Moon J; Yang EM; Ryu MS; Lee Y; Ye YM; Park HS
    PLoS One; 2022; 17(8):e0273415. PubMed ID: 35984815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
    Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
    World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopy and Response to Omalizumab Treatment in Chronic Spontaneous Urticaria.
    Costa C; Esteves Caldeira L; Paulino M; Santos DF; Silva SL
    Int Arch Allergy Immunol; 2024; 185(3):260-266. PubMed ID: 38113870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
    Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study.
    Palladino A; Villani F; Pinter E; Visentini M; Asero R
    Eur Ann Allergy Clin Immunol; 2024 Mar; ():. PubMed ID: 38482859
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.
    de Montjoye L; Darrigade AS; Giménez-Arnau A; Herman A; Dumoutier L; Baeck M
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):55-66. PubMed ID: 31965967
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria.
    Asero R; Marzano AV; Ferrucci S; Lorini M; Carbonelli V; Cugno M
    Clin Exp Immunol; 2020 Jun; 200(3):242-249. PubMed ID: 32115683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
    Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
    Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change.
    Ertas R; Ozyurt K; Atasoy M; Hawro T; Maurer M
    Allergy; 2018 Mar; 73(3):705-712. PubMed ID: 29083482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of circulating FCεRIa in Chronic Spontaneous Urticaria patients and its correlation with clinical and immunological variables.
    Baioumy SA; Esawy MM; Shabana MA
    Immunobiology; 2018 Dec; 223(12):807-811. PubMed ID: 30144948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria.
    Lal Vijayalal S; Arora S; Dabas R; Janney MS; Jankal Basavarajappa S; Das NM
    Dermatol Ther; 2020 Nov; 33(6):e14397. PubMed ID: 33040395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated MRGPRX2 Levels Related to Disease Severity in Patients With Chronic Spontaneous Urticaria.
    Cao TBT; Cha HY; Yang EM; Ye YM
    Allergy Asthma Immunol Res; 2021 May; 13(3):498-506. PubMed ID: 33733642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab in severe chronic urticaria: are slow and non-responders different?
    Asero R
    Eur Ann Allergy Clin Immunol; 2021 Nov; 53(6):263-266. PubMed ID: 32914943
    [No Abstract]   [Full Text] [Related]  

  • 15. IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?
    Altrichter S; Peter HJ; Pisarevskaja D; Metz M; Martus P; Maurer M
    PLoS One; 2011 Apr; 6(4):e14794. PubMed ID: 21532759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional.
    Altrichter S; Hawro T; Liedtke M; Holtappels G; Bachert C; Skov PS; Maurer M
    Allergy; 2018 Jul; 73(7):1497-1504. PubMed ID: 29315616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria.
    Yu L; Buttgereit T; Stahl Skov P; Schmetzer O; Scheffel J; Kocatürk E; Zawar V; Magerl M; Maurer M
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1747-1754. PubMed ID: 31025425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria.
    Schmetzer O; Lakin E; Topal FA; Preusse P; Freier D; Church MK; Maurer M
    J Allergy Clin Immunol; 2018 Sep; 142(3):876-882. PubMed ID: 29208545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment.
    Can Bostan O; Damadoglu E; Sarac BE; Kilic B; Sahiner UM; Karaaslan C; Karakaya G; Kalyoncu AF
    Dermatol Pract Concept; 2023 Oct; 13(4):. PubMed ID: 37992372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
    Larenas-Linnemann D
    Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.